Mature T/NK-cell lymphomas are a group of aggressive hematological malignancies characterized by the proliferation of mature T or natural killer (NK) cells. When these lymphomas involve the intrapelvic lymph nodes, they can lead to significant clinical manifestations, including lymphadenopathy and systemic symptoms. Accurate coding with ICD-10 Code C84.96 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.
ICD-10 Code C84.96 represents Mature T/NK-cell lymphomas that are unspecified and localized to the intrapelvic lymph nodes. This code is used when the specific subtype of T/NK-cell lymphoma is not identified, yet the clinical presentation indicates involvement of the pelvic lymphatic system. It is crucial for accurate clinical documentation and billing, particularly in oncology settings.
Mature T/NK-cell lymphomas are aggressive neoplasms arising from mature T or NK cells, often presenting with lymphadenopathy and systemic symptoms. The involvement of intrapelvic lymph nodes can complicate the clinical picture, necessitating prompt medical evaluation and intervention.
In clinical workflows, ICD-10 Code C84.96 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. This code aids in capturing the complexity of the condition, ensuring comprehensive care in both acute and chronic settings.
ICD-10 Code C84.96 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of T/NK-cell lymphoma affecting the intrapelvic lymph nodes. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Mature T/NK-cell lymphomas requires urgent medical intervention, often necessitating hospitalization for treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.96 is critical in medical billing, particularly in hospital and oncology settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, single or initial substance. |
| 96415 | Chemotherapy administration, intravenous, each additional substance. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C84.96 for Mature T/NK-cell lymphomas, unsp, intrapelvic lymph nodes
What are the common symptoms of Mature T/NK-cell lymphomas?
Common symptoms include lymphadenopathy, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and discomfort in the pelvic region due to lymph node enlargement.
How is ICD-10 Code C84.96 used in billing?
ICD-10 Code C84.96 is used in billing to document the diagnosis of Mature T/NK-cell lymphomas affecting the intrapelvic lymph nodes, ensuring accurate reimbursement for treatment and services provided.
What treatment options are available for this condition?
Treatment typically involves chemotherapy and may include immunotherapy. Supportive care is also essential to manage symptoms and monitor for complications.
When should this code be used in clinical documentation?
This code should be used when a patient is diagnosed with Mature T/NK-cell lymphoma localized to the intrapelvic lymph nodes, particularly when the specific subtype is not identified.
Clinical Notes
SOAP notes
DAP notes
AI medical notes